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Summary
The difference-in-differences (DID) approach is a well known strategy for estimating the effect of
an exposure in the presence of unobserved confounding. The approach is most commonly used
when pre- and post-exposure outcome measurements are available, and one can assume that the
association of the unobserved confounder with the outcome is equal in the two exposure groups, and
constant over time. Then, one recovers the treatment effect by regressing the change in outcome
over time on the exposure. In this paper, we interpret the difference-in-differences as a negative
outcome control (NOC) approach. We show that the pre-exposure outcome is a negative control
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outcome, as it cannot be influenced by the subsequent exposure, and it is affected by both observed
and unobserved confounders of the exposure-outcome association of interest. The relation between
DID and NOC provides simple conditions under which negative control outcomes can be used to
detect and correct for confounding bias. However, for general negative control outcomes, the DID-
like assumption may be overly restrictive and rarely credible, because it requires that both the
outcome of interest and the control outcome are measured on the same scale. Thus, we present a
scale-invariant generalization of the DID that may be used in broader NOC contexts. The proposed
approach is demonstrated on a Normative Aging Study data set, in which Body Mass Index is used
for NOC of the relationship between air pollution and inflammatory outcomes.
Key words: Location-scale models; Quantile-quantile transformation; Air pollution; Inflammation.
1. Introduction
Unmeasured confounding can seldom be ruled out in nonexperimental studies. Over the years, a
number of analytic techniques were developed in epidemiology and the social sciences to detect
and ideally, adjust for, bias due to unobserved confounding. One common approach is so-called
“difference-in-differences” (DID) estimation (Meyer, 1995; Angrist and Krueger, 1999; Blundell
and MaCurdy, 2000), which is typically used when
(i) One has observed the outcome pre- and post-exposure for each person, and
(ii) the association of the unobserved confounder with the outcome is assumed equal across expo-
sure groups and constant over time.
Then, the approach entails estimating the effect of exposure by taking a difference between exposure
groups of the average change in outcome over time.
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Another approach for evaluating the presence of confounding bias, sometimes used in epidemi-
ologic practice, consists of estimating an association between the exposure and a so-called negative
control outcome. That is, an observed outcome not causally related to the treatment, and influenced
by unmeasured confounders of the exposure-outcome relationship of primary interest (Lipsitch and
others, 2010; Tchetgen Tchetgen, 2014; Flanders and others, 2011). Thus, evidence of an associa-
tion between the exposure and the negative control outcome conditional on observed confounders
is indicative of confounding by unmeasured factors. It is of interest to identify conditions under
which the exposure-negative control outcome association gives a valid estimate of unmeasured con-
founding bias that can simply be removed (e.g. subtracted) from the estimated exposure-outcome
association to give a valid causal effect estimate.
In this paper, we interpret the DID as a negative outcome control (NOC) approach to adjust for
unobserved confounding. The equivalence follows from noting that the pre-exposure outcome in DID
is an ideal negative control outcome, since it cannot be influenced by the subsequent exposure, and
it is likely affected by both measured and unobserved risk factors for the post-exposure outcome.
We then show that assumption (ii) is equivalent to an “additive equi-confounding” assumption
that the magnitude of confounding bias for the primary outcome is equal on the additive scale to
the confounding bias for the negative control outcome. Assumptions (i) and (ii) are equivalent to
conditions under which one can use negative controls to detect − and also sometimes to correct for
− confounding bias. However, the additive equi-confounding assumption may be overly restrictive
outside of the context of pre- and post-outcome measurements, because it requires that both the
primary and negative control outcomes are measured on the same scale. As a remedy, we consider
a generalization of DID via a scale invariant approach largely motivated by the Change-in-changes
approach of Athey and Imbens (2006), that may be more broadly applicable. Our approach however
goes beyond Athey and Imbens (2006) in that we give weaker identification conditions and develop
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a flexible framework for estimation and inference using a familiar location-scale model specification
which allows one to easily incorporate a possibly large number of observed confounders. Both the
scale-invariance property of the more general approach and its ability to incorporate covariates
make our methods particularly well-suited for NOC. Importantly, while Athey and Imbens (2006)
briefly consider covariate adjustment, they rely on an assumption that the unobserved confounder
is independent of observed covariates conditional on the exposure. However, due to collider bias
stratification (Pearl, 2009; Herna´n and others, 2004), this latter assumption cannot hold if both
observed and unobserved covariates either cause or share a common cause with the exposure,
thus invalidating their proposed covariate adjustment approach when the observed covariates are
confounders. Our proposed approach also offers an alternative to the control outcome calibration
approach (COCA) of Tchetgen Tchetgen (2014) by avoiding the rank preservation assumption it
relies on, and replacing it with milder assumptions regarding a negative control outcome.
The paper is organized as follows. In Section 2 we present the NOC framework and relate it to
the DID. In Section 3 we show how negative outcomes potentially can be used in broader settings
than the classical DID, and develop a general NOC approach to indirectly account for unobserved
confounding, together with a framework for inference under a location-scale model. In Section 4 we
provide a simulation study of the proposed methods, and in Section 5 we illustrate the method by
estimating the short term effect of air pollution on blood inflammation markers, with Body Mass
Index (BMI) used as a negative outcome.
2. Notation, definitions and additive equi-confounding
Let A denote the exposure received by an individual, let Y denote a post-exposure outcome, and
let C denote a set of observed confounding variables of the effect of A on Y . Let U denote unmea-
sured confounders of the effect of A on Y . Let N denote a negative control outcome variable. The
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relationships between these variable may be depicted by the causal diagram in Figure 1.
As shown in the figure, N is a negative control outcome because it is not directly influenced by
exposure, but it is influenced by the unobserved confounders of the exposure-outcome association
(Lipsitch and others, 2010). To provide identifiability conditions for the causal effect of A on Y ,
we now consider counterfactuals or potential outcomes under possible interventions. Let Ya denote
an individual’s outcome if exposure A were set, possibly contrary to fact, to a. Similarly, let Na
denote an individual’s counterfactual value for N if A were set to a. The following assumptions
state that the negative outcome is not affected by the exposure, and that the observed exposure
outcome corresponds to the counterfactual outcome for the observed exposure value (i.e. the so-
called consistency assumption).
Assumption 1. Na = N, a = 0, 1, and Ya = Y if A = a.
The assumption that (C,U) suffice to adjust for confounding for the effect of A on Y implies
that:
E {Y0|A = 1, c, u} − E {Y0|A = 0, c, u} = 0 (2.1)
for all (c, u) , however C alone may not completely account for exposure-outcome confounding, that
is
E {Y0|A = 1, c} − E {Y0|A = 0, c} 6= 0 (2.2)
for some c, and likewise for N0 replacing Y0.
2.1 Difference-in-differences as an additive negative outcome control approach
Next, consider the longitudinal study represented in Figure 2 in which the outcome process Z(t) is
measured at 2 occasions, t = 0, 1, with Z(0) and Z(1) pre- and post-exposure variables, respectively.
According to this graph, although A is a cause of Z(1), it does not cause Z(0) (although the reverse
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may hold), and the unobserved confounder of the effect of A on Z(1), U , is also a cause of Z(0). This
causal diagram represents a typical situation under which difference-in-differences may potentially
be used to account for unobserved confounding by U . However an additional assumption about
the underlying structure of confounding is required to justify the standard DID approach, and is
described below. The similarity of the causal structure encoded in both Figures 1 and 2 is quite
striking, as Figure 1 can be obtained from Figure 2 by relabeling Z(0) as N and Z(1) as Y , thus
establishing a direct correspondence between the NOC causal framework and the DID framework.
As noted above, identification of the effect of A on Y using DID, relies on further elaboration of
the data generating mechanism under Figure 1. A simple causal model supposes that Z(t) follows
the simple linear model (where individual observations are suppressed in the notation)
E {Z(t)|U,A,C} = b(U) +m (t) + βtA+ γ (t)T C (2.3)
such that m (t) indexes a time specific intercept, γ (t) indexes a time specific association between
C and Z(t), b(U) indexes the effect of U on Z(t) which is assumed independent of t, A and C, and
β encodes the causal effect of A on Z(1). Let Za(t) denote the counterfactual outcome at t under
exposure a, and note that the key assumption encoded in equation (2.3) is that
E {Z(1)− Z(0)|U,A = a,C} = E {Z(1)− Z(0)|A = a,C} , a = 0, 1 (2.4)
which implies that C suffices to adjust for confounding between A and Z(1)− Z(0), and thus
E {Z0(1)− Z0(0)|A = 1, C} = E {Z0(1)− Z0(0)|A = 0, C} . (2.5)
Since treatment is assumed to start only after time 0, so that E[Z1(0)|A = 1, C] = E[Z0(0)|A =
1, C], and using equation 2.5, we obtain the following equality:
E {Z1(1)− Z1(0)|A = 1, C} − E {Z0(1)− Z0(0)|A = 0, C} = β (2.6)
= E(Z1(1)− Z0(1)|A = 1, C) (2.7)
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The effect identified in (2.6) defines the DID estimand under equation (2.3), and therefore under
assumption (2.4) is equal to the causal effect E {Z1(1)− Z0(1)|A = 1}, the so-called causal effect of
treatment on the treated. Interestingly, rather than assuming equation (2.3) , one may take equation
(2.5) as a primitive condition, which may hold without necessarily assuming the model given by
equation (2.3) holds exactly. Only assuming that (2.5) holds has previously been shown to suffice
for nonparametric identification of the marginal exposure effect on the exposed even when the linear
model (2.3) does not necessarily hold (Abadie, 2005). Thus, assuming no heterogeneity in the effect
of A across strata of C and U as encoded in model (2.3) is not strictly necessary to estimate the
causal effect of treatment on the treated.
2.2 Additive equi-confounding bias
Here, we are particularly interested in the following, alternative, formulation of (2.5):
E {Z0(1)|A = 1, C} − E {Z0(1) |A = 0, C} = E {Z(0)|A = 1, C} − E {Z(0)|A = 0, C}
which, upon substituting Y0 for Z0(1) and N for Z(0), is equivalently expressed:
E {Y0|A = 1, C} − E {Y0|A = 0, C} = E {N |A = 1, C} − E {N |A = 0, C} , (2.8)
where the left hand-side of (2.8) encodes the degree of confounding bias (2.2) for the effect of A
on Y , and the right hand-side of (2.8) likewise represents confounding bias for the (null) effect
of A on N . Equation (2.8) provides the “additive equi-confounding” assumption, which connects
identification in the DID approach to identification in the NOC framework.
The additive equi-confounding assumption 2.8 thus states that the magnitude of confounding
bias for estimating the effect of A on Y and that of A on N are exactly equal. Thus, we may
conclude that under additive equi-confounding, a DID type approach may be used to estimate,
in the presence of unobserved confounding and if one has access to a negative outcome control
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variable N (which may differ from a pre-exposure realization of the outcome), the conditional effect
of treatment on the treated:
α (C) = E {Y1 − Y0|A = 1, C}
or the marginal average effect of treatment on the treated:
α = E {Y1 − Y0|A = 1}
Therefore, the additive equi-confounding assumption formalizes the relation between DID and
NOC, making connection to a fairly rich literature on DID for inference under a NOC framework.
The DID literature includes several variants of the parametric strategy described above, as well
as more flexible semiparametric methods (see Abadie, 2005, and references therein). However, the
additive equi-confounding assumption may only be credible in settings where the primary and the
negative control outcomes are measured on the same scale, say as distinct realizations of the same
underlying process as in the difference-in-differences context. This restriction is well illustrated by
the linear model (2.3) in which the invariance of b(U) with respect to time encodes the equivalent
assumption for a negative outcome control, that the association between U and the primary outcome
is the same as that between U and the negative control outcome. Such an assumption may be
inappropriate even if one has available a valid negative control outcome which satisfies Figure 1.
In the next section, we consider a weaker form of equi-confounding which may be more useful in
practice for NOC.
3. Distributional equi-confounding and indirect NOC confounding adjustment
In this section, we consider a more general framework for NOC adjustment of unobserved confound-
ing under assumptions considerably less restrictive than additive equi-confounding.
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3.1 General NOC identification conditions
We relax the previous structure of unobserved confounding for Y and N , by allowing the unobserved
confounder for the effect of A on Y denoted by U , to be distinct from the unobserved confounder of
the effect of A on N , denoted W . This may be because Y and N are measured on different scales, or
because the magnitude of the effect of the unobserved confounder on N differs from the magnitude
of the effect of that confounder on Y .
Assumption 2. Aq Y0|C,U , however A 6 qY0|C, and
AqN |C,W , however A 6 qN |C.
This more general framework is depicted in Figure 3. In addition to this causal diagram, in order to
appropriately account for possible non-linearity and scale differences between the outcome and the
negative control outcome, we introduce a more general nonparametric structural equations model:
Assumption 3. Y0 and N are related to U,W and C according to
Y0 = hy (U,C) (3.9a)
N = hn (W,C) (3.9b)
where
hy (u, c) is monotone increasing in u for each c, (3.10a)
and
hn (w, c) is monotone increasing in w for each c. (3.10b)
This set of equations encodes the fact that consistent with Figure 3, U and C are parents of
Y0, and therefore are parents of Y, and likewise that W and C are parents of N . The direction of
monotonicity in equations (3.10a,3.10b) can be changed without any real consequence.
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We now consider quantile-quantile and distributional equi-confounding as a less restrictive iden-
tifying assumptions for NOC than additive equi-confounding. To proceed, we introduce the quantile-
quantile transformation, as a measure of association between two variables, which we will use to
encode confounding bias. Specifically, the quantile-quantile association between U and A conditional
on C :
q0(v|c) = FU |A=0,C=c ◦ F−1U |A=1,C=c (v) ,
v ∈ [0, 1], where FU |A,C denotes the cumulative distribution function of U conditional on A,C,
F−1U |A,C is its inverse map, and f ◦ g (x) = f(g(x)) denotes composition of functions f and g. Under
independence of U and A given C (i.e. no confounding bias), we have that q0(v|c) = v, while any
departure from the identity function encodes unobserved confounding, i.e. q0(v|c)− v 6= 0 for some
value c. Likewise let
q1(v|c) = FW |A=0,C=c ◦ F−1W |A=1,C=c (v) .
The quantile-quantile equi-confounding bias is given below.
Assumption 4. Quantile-quantile equi-confounding.
q0(v|c) = q1(v|c), v ∈ [0, 1]. (3.11)
This assumption implies that the association (on the quantile-quantile scale) between U and A
is the same as between W and A conditional on C. Quantile-quantile equi-confounding is implied
by the following somewhat stronger distributional equi-confounding bias assumption, although the
latter is still considerably weaker than additive equi-confounding:
Assumption 5. Distributional equi-confounding.
U |A,C ∼W |A,C. (3.12)
The assumption states that the conditional distribution of the unobserved confounder for Y is
the same as that for the unobserved confounder for N given A and C. Note that both assumption
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(3.11) and (3.12) are trivially satisfied, if as previously assumed, the unobserved confounder of Y
and N is the same, i.e. U = W . Note also that both assumptions are considerably weaker than
the previous additive equi-confounding assumption (2.8) because they place no restriction on the
relationship between U and Y0, and likewise for the relationship between W and N . Crucially, they
are both invariant in a monotone transformation of the outcome, and therefore, do not suffer from
the scale restriction of additive equi-confounding.
The following Theorem 1 establishes nonparametric identification of the marginal effect of treat-
ment on the treated α under quantile-quantile equi-confounding, and therefore also under distribu-
tional equi-confounding. It requires an additional regularity condition:
Assumption 6. Positivity.
If 0 < f(N∗|A = 1, C), then 0 < FN |A=0,C(N∗) < 1 (3.13)
This condition ensures that values of the negative outcome in the exposed are in the support of
the distribution of the negative outcome in the unexposed, and the probability FN |A=C(N∗) will
not be identically 1 or 0 for some set of plausible values of N∗ ∼ N |A = 1, C.
Theorem 1 : Let N∗ ∼ N |A = 1, C. Under assumptions 1-4 and 6, we have that
α = E {Y1 − Y0|A = 1}
= E {Y |A = 1} − E
{
Y˜
}
where
Y˜ ∼ F−1Y |A=0,C ◦ FN |A=0,C (N∗)
By consistency, we have that E(Y1|A = 1) = E(Y |A = 1); therefore the main result of the the-
orem is to establish identification of the conditional counterfactual mean E(Y0|A = 1) under our
assumptions about the nature of confounding and the availability of a negative control outcome.
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The theorem is a negative control analog of a similar identification result in the change-in-changes
approach of Athey and Imbens (2006), which they obtain under a more stringent assumption anal-
ogous to distributional equi-confounding. Whereas Athey and Imbens (2006)’s primary goal was to
account for possible non-linearity in a DID context, our primary concern has been to account for
possible differential scaling in a NOC context, and to demonstrate the close relationship between
these contexts as established by the above result. The isomorphism between the two frameworks
further provides a principled framework for NOC of unobserved confounding, possibly using a post-
exposure outcome to achieve such control. The result also offers a useful alternative to COCA of
Tchetgen Tchetgen (2014) which requires rank preservation of the primary outcome, i.e. that the
rank of Ya is preserved under treatment versus control conditions.
3.2 Indirect NOC adjustment in the location-scale model
For inference, we discuss indirect adjustment under a location-scale semiparametric model. Specifi-
cally, suppose that both Y and N follow a location-scale model conditional on C in the unexposed,
with A = 0. Let
E (N |A = 0, C) = µn (C)
V ar (N |A = 0, C) = s2n (C) ,
and εN =
N − µn (C)
sn (C)
,
and likewise, let
E (Y |A = 0, C) = µy (C)
V ar (Y |A = 0, C) = s2y (C)
and εY =
Y − µy (C)
sy (C)
.
Then the location-scale models for Y and N states that
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εN |A = 0, C ∼ fN (εN ), εY |A = 0, C ∼ fY (εY ), (3.14)
where fY (·) and fN (·) are unrestricted baseline densities. The following Corollary is obtained:
Corollary 1 Under the assumptions stated in Theorem 1 and the location-scale model (3.14) , we
have that
Y˜ = sY (C)
{
F−1Y ◦ FN
(
N∗ − µn (C)
sn (C)
)}
+ µy (C) , (3.15)
and in the special case where FN (·) = FY (·), then
Y˜ = sy (C)
{
N∗ − µn (C)
sn (C)
}
+ µy (C) , (3.16)
where N∗ and Y˜ are given in Theorem 1.
Note also that if FN (·) = FY (·), then the regularity condition 6 is not strictly required. Next,
we describe a simple practical implementation of the NOC adjustment given in Corollary 1, first
assuming a location-scale family allowing FN (·) and FY (·) to be different, and then further assuming
FN (·) = FY (·).
Let µ̂n(·), µ̂y(·) be estimators of the mean functions for the negative and primary outcomes
under no exposure, and let ŝn(·), ŝy(·) denote estimators of the standard deviations of N and Y .
These can be obtained using standard models for mean and variance regression, e.g. one may take
µ̂n (C) = pi0 + pi
′
1C the ordinary least squares estimator of E(N |A = 0, C) using the subsample
with A = 0, and likewise one may take ŝ2n (C) = exp (ω̂0 + ω̂
′
1C) a standard log-linear regression of
the squared N − µn(C) in the unexposed subsample, and similarly for µ̂y (·) and ŝy (·) . Further,
let F̂N (·) and F̂Y (·) be non-parametric estimators of the cumulative distribution functions of N
and Y in the unexposed, estimated as follows: based on µ̂y(·), ŝy(·), scaled residuals are obtained as
̂i = {Yi − µ̂y(Ci)}/sy(Ci), i = 1, . . . , n0 for the outcome Y , in the n0 unexposed. These residuals
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are used to obtain the empirical estimate of FY (·) non-parametrically,
F̂Y (u) =
1
n0
n0∑
i=1
I{i 6 u},
where I(i 6 u) is the indicator function. Similarly, F̂N (·) is obtained for the negative outcome N .
1. Following Theorem 1 and Corollary 1, an estimator of α is obtained by substitution, i.e.
α̂1 =
∑
i:Ai=1
Yi − ŝy (Ci)
{
F̂−1Y ◦ F̂N
(
N∗−µ̂n(Ci)
ŝn(Ci)
)}
− µ̂y (Ci)∑
i:Ai=1
1
. (3.17)
2. Assuming FN (·) = FY (·), (3.17) simplifies to:
α̂2 =
∑
i:Ai=1
Yi − ŝy (Ci)
(
N∗−µ̂n(Ci)
ŝn(Ci)
)
− µ̂y (Ci)∑
i:Ai=1
1
. (3.18)
3. Under homoscedasticity, i.e. ŝy(Ci) = ŝy for all Ci, and similarly for ŝn, upon rearranging:
α̂3 =
∑
i:Ai=1
[Yi − µ̂y (Ci)]∑
i:Ai=1
1
− ŝy
ŝn
[N∗ − µ̂n (Ci)]∑
i:Ai=1
1
= η̂y − ŝy
ŝn
η̂n (3.19)
where η̂y and η̂n are the standard estimators of the effect of treatment on the treated for
Y and N respectively. This formulation provides some intuition for the proposed indirect
adjustment, whereby the standard estimator of theA−Y association is adjusted by subtracting
an estimator of the magnitude of confounding bias given by the scaled association between
N and A, with scaling factor ŝy/ŝn. The scaling factor is necessary here, to account for
possible scale differences between N and Y , or between the magnitude of the effect of the
unmeasured confounder on N and Y . The more complicated estimator α̂1 further accounts
for distributional differences and possible heteroscedasticity.
In the appendix, we provide a simple expression for the large sample variance of α̂2 which may
be used to construct confidence intervals; alternatively, we recommend using the nonparametric
bootstrap for inference.
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4. Simulation study
We conducted a simulation study to demonstrate the applicability of our proposed indirect NOC
adjustment under a location-scale model. We generated data from the model defined by
Y = (U + η0 + Cηc +Aα˜)× σy
N = (W + β0 + Cβc)× σn
with U and W from the same location-scale family. We set σy = 3, σn = 1.5, (η0, ηc)
T = (1, 2)T ,
(β0, βc)
T = (2, 3)T , and α˜ = 1, so the exposure effect on the unexposed amounted to α = α˜×σy = 3.
To simulated confounding bias between exposure groups, we determined the distribution of C,U
and W by exposure status. U and W came from either a normal or a uniform distribution, with
U,W |A = 0 ∼ N (0, 1.5), and U,W |A = 1 ∼ N (2, 1.5), or U,W |A = 0 ∼ uniform(1, 9) and
U,W |A = 1 ∼ uniform(3, 13). The observed confounder had C|A = 0 ∼ N (0, 1), C|A = 1 ∼
N (0.5, 1).
Note that a na¨ıve analysis ignoring the possibility of unmeasured confounding between exposure
groups would attribute the difference in means
E[Y |A = 1, C]− E[Y |A = 0, C] = α+ (E[U |A = 1]− E[U |A = 0])× σy
solely to the effect of treatment, when the term (E[U |A = 1]− E[U |A = 0]) × σy is in fact the
bias, and is equal to 6 when U and W are normally distributed, and 9 when they are uniformly
distributed. Also note that under the uniform distribution scenario, the positivity assumption 6 does
not hold, and therefore the estimator α1 from Section 3.2 may be biased. However the estimator
α2 that assumes FN (·) = FY (·) will not be biased, since in this case the positivity assumption is
not required.
We generated data with n = 100, 500 observations, with n/2 observations in each exposure
group. We compared the accuracy of the estimators proposed in Section 3.2 over 1000 simulations.
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Note that although both outcomes Y and N are generated under homoscedastic errors, with U and
W following a common distribution given A and C, nonetheless, we consider inferences about the
effect of treatment on the treated using the methods developed in previous sections both with and
without imposing these assumptions. In addition, we compare the estimator of α using NOC to the
na¨ıve regression estimator that regresses Y on A and C.
Table 1 provides the absolute bias and MSE of the estimator of treatment effect on the treated
for each of the various scenarios and assumptions described above. Using N for negative outcome
control assuming a location-scale model yields very good results. The data were simulated with ho-
moscedastic errors and a common location-scale family for Y and N , so that the qq-transformation
between the standardized Y and N in the unexposed group is the identity. Accordingly, when ho-
moscedasticity and identity qq-transformations were assumed, the estimated effects are unbiased
and the MSE is smallest compared to other scenarios. Relaxing the homoscedasticity assumption and
modeling the variance via a log-linear model resulted in only slightly larger MSEs. However, mod-
eling the qq-transformation between the standardized Y and N in the unexposed group had mixed
effects. Under normal distribution of the unobserved confounders, modeling the qq-transformation
had little effect on the bias and efficiency of the estimators. However, under uniform distribution of
the unmeasured confounders, modeling this transformation resulted in substantially larger MSEs
and biased estimators. This is because the positivity condition did not hold. The na¨ıve estimator
that regresses Y against A and C showed had the expected bias.
5. Data analysis
We implemented the proposed NOC indirect adjustment to account for confounding in studying
the effect of short term (4 weeks) exposure to black carbon (BC, an air pollution component) on
fibrinogen, a blood inflammation marker. We selected BMI as the negative control outcome, since
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BMI is likely not affected by short term exposure to air pollution, while it likely shares unmeasured
confounders with inflammation markers. In prior work by Zeka and others (2006), fibrinogen levels
were shown to be associated with 4 weeks exposure to BC in the Normative Aging Study (NAS)
cohort. The investigators took 4 weeks moving average of BC, measured at an areal sensor, just
prior to a clinic visit as the exposure, and adjusted to multiple confounders, including BMI. We
now reuse this data set.
The NAS is a longitudinal study following a cohort of US veterans. They report to the clinic
every 3-4 years. We consider a data set of complete cases (i.e. includes exposure, adjusting variables,
and outcome values) from visits between November 14, 2000 and December 31, 2004, as in Zeka and
others (2006). We use BC values measured either at the areal sensor in Boston (as in Zeka and others
(2006)), or geospatial model-predicted values at participants’ home addresses (Gryparis and others,
2007). The covariates were age and weather-related variables: season, mean barometric pressure,
relative humidity, and temperature in the 24 hours preceding the clinic visit. Table 3 provides the
cohort characteristics. BC is dichotomized and set to 0 if BC is less than the median observed in
the data (“low exposure”), and 1 otherwise (“high exposure”) .We implemented the four models
compared in the simulations, i.e. the more robust models allowing for heteroscedasticity, and/or
different location-scale family, and the model that assumes homoscedasticity and same location-scale
family. In addition to these models of indirect adjustment, we also compared the analysis to the
a na¨ıve regression analysis that regresses log-fibrinogen on the BC measure of interest, covariates,
and BMI, and to the “DID” analysis that assumes that the negative control outcome log-BMI is
measured on the same scale as the primary outcome log-fibrinogen. Note that this is not in fact the
standard DID, as log-BMI is obviously not the baseline measure of log-fibrinogen.
We evaluated the assumptions on the distributions of Y and N . To evaluate the assumption
of a common location-scale family of Y and N , we considered the histograms of scaled residuals
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of BMI, fibrinogens, and their log-transformation in the low-exposure group, after regressing on
covariates. These histograms are provided in Figure 7. One can see that after log-transformation
both the primary and control outcomes have symmetric distributions, and it is reasonable to assume
that they are sampled from the same location-scale family. We also observed that log-fibrinogen
and log-BMI are measured on different scales. Next, we assessed the homoscedasticity assumption
on the residuals of Y and N in the low exposure group. We used a 5-fold cross validation of the
restricted data set, where in each “fold” we took a fourth of the participants, and generated mean
and variance models to predict the outcomes (log-fibrinogen) of the held-out fifth of the participants.
We calculated the mean squared errors for these predictions as
∑nk
i=1((yi − Cβ̂y)2 − exp(Cω̂y))2,
where nk is the number of observation in the k = 1, . . . , 5 set of observations, β̂y is the vector of
regression coefficients of the outcome y, and ω is the vector of regression coefficients in the log-linear
models of the residuals. The cross-validated prediction score is the mean of these 5 scores. Table 2
provides the results of these cross validations, and they suggest that modeling the variances of both
Y and N conditional on covariates is beneficial.
Figure 5 provides effect estimates using the various models described above, and their 95%
bootstrap confidence intervals from 1000 bootstrap samples. One can see that when using more
robust models (that make fewer assumptions), the confidence intervals are wider, in agreement
with the simulations studies, in which MSEs were larger for more general models. Consider the
dichotomized (high vs low) BC exposure measured at an areal sensor. For this model, based on
the histograms in Figure 4 and the results from assesing heteroscedasticity in Table 2, the most
appropriate estimates assumes that Y and N come from the same location-scale family (“same
LS” in the figure) and, the variance varies within levels of covariates (“var(C)” in the figure).
Interestingly, in this case the effect estimates of BC are larger than the standard regression estimate.
The “DID” analysis had hardly any impact on the results compared to the ordinary regression
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analysis, since log-BMI is measured on a different scale than log-fibrinogen, and more accurately -
in values much closer to zero. This demonstrates the importance of accounting for the outcome’s
scale in DID-type analysis. More generally, even if the negative outcome is the same as the primary
outcome, there may be difference in variances across groups that are important to account for.
Interestingly, when using the predicted BC measures at the participants’ home addresses, BC
effect estimates are closer to null. This is likely due to measurement error from the geospatial model
used to predict the BC measurements. Such models were shown to often lead to biases towards the
null in estimating air pollution effects (Zeger and others, 2000).
In contrast with standard regression, estimates based on NOC approaches under different
location-scale families found no significant exposure effect; however, confidence intervals from all
models contained the point estimate obtained using standard regression, suggesting that BMI does
not provide any significant evidence of unobserved confounding bias.
6. Software
Software in the form of R code, together with a sample input data set and complete documentation
is available on request from the corresponding author (etchetge@hsph.harvard.edu).
7. Supplementary Material
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APPENDIX
A. Mathematical derivations
Proof of Theorem 1: Let SN |A,C (n) = P {N > n|A,C} and FN |A,C (n) = P {N < n|A,C} .
First we establish that assumption (3.11) is equivalent to:
FY0|A=0,C ◦ F−1Y0|A=1,C (v) = FN |A=0,C ◦ F
−1
N |A=1,C (v)
since
FY0|A=0,C ◦ F−1Y0|A=1,C (v)
= Pr
{
Y0 6 F−1Y0|A=1,C (v) |C,A = 0
}
= Pr
{
hy (U,C) 6 F−1Y0|A=1,C (v) |C,A = 0
}
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N A Y
U
C
Fig. 1. Directed acyclic graph depicting the causal association between the treatment A, primary outcome
Y , negative control outcome N , measured pre-exposure confounders C, and unmeasured confounders U .
Z(0) A Z(1)
U
C
Fig. 2. Directed acyclic graph depicting the causal association between the treatment A, pre-exposure
outcome Z(0), post-exposure outcome Z(1), measured pre-exposure confounders C, and unmeasured con-
founders U .
Table 1. Finite sample bias and MSE (in parenthesis) averaged over 1000 simulations, for estimat-
ing the effect of treatment on the treated (α = 3) via indirect adjustment, under the location-scale
model. The unmeasured confounders were sampled from either the normal or the uniform family.
The Na¨ıve model is the regression estimator of Y on C and A. Other estimators either assume
homoscedasticity, or model the variance as a function of covariates C, and either assume that the
qq-transformation between the standardized primary outcome Y and the negative control outcome
N in the unexposed group is the identity (“QQ identity”), or model this transformation nonpara-
metrically.
Family n Na¨ıve Assuming homoscedasticity Modeling the variance
regression QQ identity QQ modeled QQ identity QQ modeled
Normal 100 5.99(36.83) 0.05(02.72) 0.47(02.54) 0.13(02.99) 0.52(02.65)
Normal 500 5.99(36.06) 0.01(00.53) 0.12(00.57) 0.03(00.59) 0.12(00.61)
Uniform 100 9.09(85.15) 0.03(05.65) 2.61(10.06) 0.03(05.98) 2.59(10.03)
Uniform 500 8.97(81.02) 0.01(01.23) 2.34(06.22) 0.03(01.27) 2.31(06.10)
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and note that
FY0|A=1,C (y) = Pr {Y0 6 y|C,A = 1}
= Pr {hy (U,C) 6 y|C,A = 1}
= Pr
{
U 6 h−1y (y, C) |C,A = 1
}
= FU |C,A=1
(
h−1y (y, C)
)
so that
F−1Y0|A=1,C (v) = hy
(
F−1U |C,A=1 (v) , C
)
and therefore we may conclude that
FY0|A=0,C ◦ F−1Y0|A=1,C (v)
= Pr
{
hy (U,C) 6 F−1Y0|A=1,C (v) |C,A = 0
}
= Pr
{
hy (U,C) 6 hy
(
F−1U |C,A=1 (v) , C
)
|C,A = 0
}
= Pr
{
U 6 F−1U |C,A=1 (v) |C,A = 0
}
= FU |A=0,C ◦ F−1U |A=1,C (v)
Likewise,
FN |A=0,C ◦ F−1N |A=1,C (v) = FW |A=0,C ◦ F−1W |A=1,C (v)
proving
FU |A=0,C ◦ F−1U |A=1,C (v) = FW |A=0,C ◦ F−1W |A=1,C (v) (A.1)
⇐⇒ FY0|A=0,C ◦ F−1Y0|A=1,C (v) = FN |A=0,C ◦ F
−1
N |A=1,C (v)
the result.
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Proof of Corollary 1: From Theorem 1
Y˜ ∼ F−1Y |A=0,C ◦ FN |A=0,C (N∗) .
First, note that
FN |A=0,C(v) = p(N < v|A = 0, C) = p
(
N − µn(C)
sn(C)
<
v − µn(C)
sn(C)
∣∣∣∣A = 0, C)
= FN
(
v − µn(C)
sn(C)
)
.
Second, let F−1Y |A=0,C(u) = v, for 0 < u < 1. The inverse probability function can be defined as
F−1Y |A=0,C(u) = min{v : p(Y < v|A = 0, C) = u}. Then:
u = FY |A=0,C(v) = p(Y < v|A = 0, C) = p
(
Y − µy(C)
sy(C)
<
v − µy(C)
sy(C)
∣∣∣∣A = 0, C)
= FY
(
v − µy(C)
sy(C)
)
Thus,
v = sy(C)F
−1
Y (u) + µy(C) = F
−1
Y |A=0,C(u).
Combining the two results, we get:
Y˜ = sy(C)F
−1
Y ◦ FN
(
N∗ − µn(C)
sn(C)
)
+ µy(C).
Now, if FY (·) = FN (·), trivially
Y˜ = sy(C)
(
N∗ − µn(C)
sn(C)
)
+ µy(C).
B. Asymptotic variance of the location-scale NOC estimate
Assume that sy(Ci) = sy, sn(Ci) = sn. The estimating equation U(θ) for θ = (βy,βn, sy, sn, α) is
given by
U(θ) =

U(βy)
U(βn)
U(s2y;βy)
U(s2n;βn)
U(α)

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with influence function
E
[
∂
∂θ
U(θ)
]−1
U(θ)
with:
U(βy) =
1∑
i:Ai=0
1
∑
i:Ai=0
Ci
(
Yi − CTi βy
)
U(βn) =
1∑
i:Ai=0
1
∑
i:Ai=0
Ci
(
Ni − CTi βn
)
U(sy) =
1∑
i:Ai=0
1
∑
i:Ai=0
(
Yi − CTi βy
)2 − s2y
U(sn) =
1∑
i:Ai=0
1
∑
i:Ai=0
(
Ni − CTi βn
)2 − s2n
U(α) =
1∑
i:Ai=1
1
∑
i:Ai=1
[
Yi − sy
{
N∗ − CTi βn
sn
}
− CTi βy
]
− α.
The matrix ∂
∂θ
U(θ) is given by:
∂
∂βy
U(βy) 0 0 0 0
0 ∂
∂βn
U(βn) 0 0 0
∂
∂βy
U(sy) 0
∂
∂sy
U(sy) 0 0
0 ∂
∂βn
U(sn) 0
∂
∂sn
U(sn) 0
∂
∂βy
U(α) ∂
∂βn
U(α) ∂∂syU(α)
∂
∂sn
U(α) ∂∂αU(α)
,

with:
∂
∂βy
U(βy) = −
1∑
i:Ai=0
1
∑
i:Ai=0
CiC
T
i
∂
∂βn
U(βn) = −
1∑
i:Ai=0
1
∑
i:Ai=0
CiC
T
i
∂
∂βy
U(sy) = − 2∑
i:Ai=0
1
∑
i:Ai=0
Ci
(
Yi − CTi βy
)
∂
∂sy
U(sy) = −2sy
∂
∂βn
U(sn) = − 2∑
i:Ai=0
1
∑
i:Ai=0
Ci
(
Ni − CTi βn
)
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∂
∂sn
U(sy) = −2sn
∂
∂βy
U(α) = − 1∑
i:Ai=1
1
∑
i:Ai=1
CTi
∂
∂βn
U(α) =
1∑
i:Ai=1
1
∑
i:Ai=1
sy
sn
CTi
∂
∂sy
U(α) = − 1∑
i:Ai=1
1
∑
i:Ai=1
{
N∗ − CTi βn
sn
}
∂
∂sn
U(α) =
1∑
i:Ai=1
1
∑
i:Ai=1
sy
{
N∗ − CTi βn
s2n
}
∂
∂α
U(α) = −1.
Finally, the covariance matrix of the estimators is given by
[
∂
∂θ
U(θ)
]−1
Pn
[
Ui(θ)U
T
i (θ)
] [ ∂
∂θ
U(θ)
]−1
,
where Ui is an individual equation for subject i, and Pn[xi] = 1/n
∑n
i=1 xi.
[Received August 1, 2010; revised October 1, 2010; accepted for publication November 1, 2010 ]
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Fig. 3. Directed acyclic graph depicting the causal association between the treatment A, primary outcome
Y , negative control outcome N , measured pre-exposure confounders C, and unmeasured confounders U and
W of the primary and secondary outcomes, respectively.
Table 2. 5-fold cross-validated prediction scores comparing two models for the variances. The ‘ho-
moscedasticity’ option assumes homoscedasticity across all levels of the confounding variables, and
‘model variance’ assumes that the covariates affect the error variance via a log-linear model.
Outcome homoscedasticity model variance
log-fibrinogen 0.032 0.007
log-BMI 0.032 0.001
Table 3. NAS cohort characteristics, for participants observed between November 2000 and Decem-
ber 2004. Measures are given in medians and ranges are in parentheses.
Characteristic value
Number of participants 616
Number of visits 703
Age 74 (58, 92)
BMI 27.6 (17.9, 46)
Fibrinogen 328 (109, 741)
Black carbon concentration (Areal) 1.18 (0.32, 2.02)
Black carbon concentration (Address) 0.75 (0.42, 1.17)
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Fig. 4. Histograms of the residuals of the primary outcome (fibrinogen) and negative control outcome (BMI),
and their log transformations, after regressing on the covariates in the low-exposure group.
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Fig. 5. Estimates of the effect of exposures to BC on log-fibrinogen as a binary variable, with values either
predicted at participants’ home addresses (left), or measured at an areal sensor at Boston (right), and
95% bootstrap confidence intervals. Effects were estimated using the indirect adjustment method with
log-BMI as the negative control outcome, and compared to standard regression adjusted to BMI, and to
the na¨ıve DID method that assumes that the negative control outcome log-BMI is measured at the same
scale as the primary outcome. var(1) and var(C) refer to modeling the variance using a log-linear model
assuming dependence on covariates (var(C)), or homoscedasticity (var(1)). The location-scale family (LS)
of log-fibrinogen and log-BMI were assumed identical (“same”) or different (“diff”).
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